Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
966
-
Total 13F shares, excl. options
-
123,323,995
-
Shares change
-
+1,132,471
-
Total reported value, excl. options
-
$32,917,825,335
-
Value change
-
+$384,787,916
-
Put/Call ratio
-
87.97%
-
Number of buys
-
407
-
Number of sells
-
-444
-
Price
-
$267
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2022
1,120 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2022.
BIOGEN INC. - COM (BIIB) has 966 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123,323,995 shares
of 146,614,676 outstanding shares and own 84.11% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15,741,715 shares), BlackRock Inc. (13,846,724 shares), VANGUARD GROUP INC (11,914,973 shares), STATE STREET CORP (6,895,357 shares), WELLINGTON MANAGEMENT GROUP LLP (5,135,617 shares), GEODE CAPITAL MANAGEMENT, LLC (3,299,475 shares), JPMORGAN CHASE & CO (2,103,917 shares), Clearbridge Investments, LLC (1,875,640 shares), NORTHERN TRUST CORP (1,685,021 shares), and Point72 Asset Management, L.P. (1,677,982 shares).
This table shows the top 966 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.